Ratings by Jones Trading (Sean Kim)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2024 | CymaBay Therapeutic | CBAY | Downgrade | Hold (Buy) |
32.46 (32.48) |
0.06% | Details | |
| 2/13/2024 | CymaBay Therapeutic | CBAY | Downgrade | Hold (Buy) |
25.69 (32.48) |
26.43% | Details | |
| 2/12/2024 | CymaBay Therapeutic | CBAY | Downgrade | Hold (Buy) |
25.69 (32.48) |
26.43% | Details | |
| 12/4/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Durect Corp | DRRX | Downgrade | Hold (Buy) |
2.58 (1.91) |
-25.97% | Details | |
| 11/8/2023 | Arcutis Biotherapeutics Inc. | ARQT | Downgrade | Hold (Buy) |
2.34 (24.00) |
925.64% | Details | |
| 8/18/2023 | Impel Pharmaceuticals Inc | IMPL | Downgrade | Hold (Buy) |
0.63 (0.24) |
-61.9% | Details | |
| 6/14/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | New Coverage | Buy (N/A) |
6.31 (15.75) |
149.6% | Details | |
| 6/14/2023 | Ovid Therapeutics Inc | OVID | New Coverage | Buy (N/A) |
3.69 (1.91) |
-48.24% | Details | |
| 3/20/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2023 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
1.69 (13.30) |
686.98% | Details | |
| 3/14/2023 | Durect Corp | DRRX | New Coverage | Buy (N/A) |
4.65 (1.91) |
-58.92% | Details | |
| 1/20/2023 | Concert Pharmaceuticals | CNCE | Downgrade | Hold (Buy) |
8.29 (8.37) |
0.97% | Details | |
| 11/16/2022 | Satsuma Pharmaceuticals | STSA | Downgrade | Hold (Buy) |
0.63 (1.10) |
74.6% | Details | |
| 9/21/2022 | Arcutis Biotherapeutics Inc. | ARQT | New Coverage | Buy (N/A) |
19.23 (24.00) |
24.8% | Details | |
| 8/25/2022 | Impel Neuropharma | IMPL | New Coverage | Buy (N/A) |
7.45 (0.24) |
-96.78% | Details | |
| 8/25/2022 | Concert Pharmaceuticals | CNCE | New Coverage | Buy (N/A) |
6.97 (8.37) |
20.09% | Details | |
| 8/25/2022 | Satsuma Pharmaceuticals | STSA | New Coverage | Buy (N/A) |
6.02 (1.10) |
-81.73% | Details |
